Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSIONS: The botulinum toxin B-induced dry eye mouse model is potentially useful in evaluating new dry eye treatment. Evaluation of important molecular biomarkers suggests that C-NAC may impart some protective ocular surface properties. However, clinical data did not indicate statistically significant improvement of tear production and corneal staining in any of the groups tested. CLINICAL RELEVANCE: Topically applied C-NAC might protect the ocular surface in dry eye syndrome, as evidenced by decreased inflammatory cytokine expression.
|
Authors | Teeravee Hongyok, Jemin J Chae, Young Joo Shin, Daero Na, Li Li, Roy S Chuck |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 127
Issue 4
Pg. 525-32
(Apr 2009)
ISSN: 1538-3601 [Electronic] United States |
PMID | 19365035
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Ophthalmic Solutions
- RNA, Messenger
- chitosan-N-acetylcysteine conjugate
- rimabotulinumtoxinB
- Chitosan
- Botulinum Toxins
- Botulinum Toxins, Type A
- Fluorometholone
- Acetylcysteine
|
Topics |
- Acetylcysteine
(administration & dosage, pharmacology)
- Administration, Topical
- Animals
- Blinking
(physiology)
- Botulinum Toxins
- Botulinum Toxins, Type A
- Chitosan
(administration & dosage, analogs & derivatives, pharmacology)
- Conjunctiva
(metabolism)
- Cornea
(metabolism)
- Cytokines
(genetics, metabolism)
- Disease Models, Animal
- Dry Eye Syndromes
(chemically induced, drug therapy, metabolism)
- Female
- Fluorescent Antibody Technique, Indirect
- Fluorometholone
(administration & dosage, pharmacology)
- Lacrimal Apparatus
(metabolism)
- Mice
- Mice, Inbred CBA
- Ophthalmic Solutions
(administration & dosage, pharmacology)
- RNA, Messenger
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Tears
(metabolism)
|